{"disease":{"id":"cancer-of-unknown-primary-site","name":"cancer of unknown primary site"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03498521","title":"A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":529,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT04952103","title":"Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03278600","title":"Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":182,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05263700","title":"FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Peter MacCallum Cancer Centre, Australia","has_results":false},{"nct_id":"NCT07372963","title":"18F-FAPI PET in Cancers of Unknown Primary Site","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT04750109","title":"Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers","phase":"","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"The Christie NHS Foundation Trust","has_results":false},{"nct_id":"NCT01845337","title":"Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT03752333","title":"Trial of Pembrolizumab in Cancer of Unknown Primary","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT05841966","title":"Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03053466","title":"APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Apollomics (Australia) Pty. Ltd.","has_results":false},{"nct_id":"NCT04459273","title":"Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05024968","title":"Sintilimab in Cancer of Unknown Primary","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}